Search Ontology:
ChEBI
dihydroergotamine
- Term ID
- CHEBI:4562
- Synonyms
-
- (10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
- 5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
- 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
- 9,10-dihydroergotamine
- dihidroergotamina
- Dihydroergotamine
- dihydroergotaminum
- Definition
- Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.
- References
-
- Beilstein:78887
- CAS:511-12-6
- DrugBank:DB00320
- Drug_Central:888
- KEGG:C07798
- KEGG:D07837
- KNApSAcK:C00001724
- LINCS:LSM-3619
- PMID:10954953
- PMID:20132337
- PMID:8145914
- Wikipedia:Dihydroergotamine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from dihydroergotamine
Phenotype where environments contain dihydroergotamine
Phenotype modified by environments containing dihydroergotamine
Human Disease Model